Page title
Search SAMHSA Publications and Digital Products
Store Facets Summary
Main page content
Displaying results 21 - 26 of 26
Clinical Supervision and Professional Development of the Substance Abuse Counselor
Published: October 2013
This guide offers tips for program administrators on developing an effective program for clinical supervision in the substance use disorder treatment field. It addresses cultural competence, and describes supervisor ethics and values.
Clinical Supervision and Professional Development of the Substance Abuse Counselor
Published: September 2013
This guide offers tips for clinical supervisors in the substance use disorder treatment field. It covers functions of a clinical supervisor, and highlights stages of professional development for counselors and clinical supervisors.
A Guide to Substance Abuse Services for Primary Care Clinicians
Published: December 2012
This manual guides clinicians through stages of primary care for alcohol and substance misuse in adult patients. It discusses warning signs of misuse, screening and follow-up, brief intervention, assessment, treatment models, and legal issues. It includes four screening tools.
Enhancing Motivation for Change in Substance Abuse Treatment
Published: December 2012
This manual presents guidelines for enhancing motivation among patients in treatment for alcohol and substance misuse. It describes several motivational approaches, ways to integrate these approaches, and two assessment tools.
Substance Abuse Treatment for Persons With Co-Occurring Disorders
Published: June 2010
This manual offers mental health professionals models and techniques for working with people living with co-occurring disorders. It describes screening and assessment and lists five guiding principles for effective management.
Incorporating Alcohol Pharmacotherapies Into Medical Practice
Published: May 2010
This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.